Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.70 |
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.55 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.55 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.55 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.55 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.55 |
| ▸ | MGLL | Q99685 | 1/20 | 0.53 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.53 |
| ▸ | P2RY10 | O00398 | 3/20 | 0.50 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.50 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10037040 | 0.89 | FAAH (0.73) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL11260384 | 0.89 | DGKA (0.77) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL11260379 | 0.89 | DGKA (0.77) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL23268626 | 0.88 | FAAH (0.90) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL9905934 | 0.88 | FAAH (0.90) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL9905946 | 0.87 | FAAH (0.52) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL1899258 | 0.86 | FAAH (0.82) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL15516648 | 0.86 | FAAH (0.86) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL9905955 | 0.85 | ALDH1A1 (0.66) | FAAHDGKACNR1ALDH1A1MAPT | |
| SCHEMBL9905962 | 0.85 | ADORA3 (0.64) | FAAHDGKACNR1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2017-01-19 | — | — | US | disclosed |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2017-01-19 | — | — | US | disclosed |
| US-9480660-B2 | Methods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof | SCF PHARMA INC. (CA) | 2016-11-01 | — | — | US | disclosed |
| US-9480660-B2 | Methods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof | SCF PHARMA INC. (CA) | 2016-11-01 | — | — | US | disclosed |
| US-9233915-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | SCF PHARMA INC. (CA) | 2016-01-12 | — | — | US | disclosed |
| US-9233915-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | SCF PHARMA INC. (CA) | 2016-01-12 | — | — | US | disclosed |
| EP-2121576-B1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | CT DE RECH SUR LES BIOTECHNOLOGIES MARINE (CA) | 2015-11-11 | — | — | EP | disclosed |
| US-9101563-B2 | Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof | SCF PHARMA INC (CA) | 2015-08-11 | — | — | US | disclosed |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-08-05 | — | — | US | disclosed |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-08-05 | — | — | US | disclosed |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-06-24 | — | — | US | disclosed |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-06-24 | — | — | US | disclosed |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| WO-2008113177-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008098375-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | FAAH 871/4885DGKA 40/4885CNR1 3047/4885 |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | FAAH 225/4885DGKA 36/4885CNR1 2684/4885 |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | PPARG, PTGES, PTGIS | FAAH 267/4885DGKA 102/4885CNR1 3031/4885 |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | FAAH 871/4885DGKA 40/4885CNR1 3047/4885 |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | FAAH 225/4885DGKA 36/4885CNR1 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.